Modeling the VPAC2-activated cAMP/PKA signaling pathway: from receptor to circadian clock gene induction.

Increasing evidence suggests an important role for VPAC2-activated signal transduction pathways in maintaining a synchronized biological clock in the suprachiasmatic nucleus (SCN). Activation of the VPAC2 signaling pathway induces per1 gene expression in the SCN and phase-shifts the circadian clock. Mice without the VPAC2 receptor lack an overt, coherent circadian rhythm in clock gene expression, SCN neuron firing rate, and locomotor behavior. Using a systems approach, we have developed a kinetic model integrating VPAC2 signaling mediated by the cyclic AMP (cAMP)/protein kinase A (PKA) pathway and leading to induced circadian clock gene expression. We fit the model to experimental data from the literature for cAMP accumulation, PKA activation, cAMP-response element binding protein phosphorylation, and per1 induction. By linking the VPAC2 model to a published circadian clock model, we also simulated clock phase shifts induced by vasoactive intestinal polypeptide (VIP) and matched experimental data for the VIP response. The simulated phase response curve resembled the hamster response to a related neuropeptide, GRP1-27, and light. Simulations using pulses of VIP revealed that the system response is extraordinarily robust to input signal duration, a result with physiologically relevant consequences. Lastly, simulations using varied receptor levels matched literature experimental data from animals overexpressing VPAC2 receptors.

[1]  H. Piggins,et al.  Vasoactive intestinal polypeptide phase-advances the rat suprachiasmatic nuclei circadian pacemaker in vitro via protein kinase A and mitogen-activated protein kinase , 2004, Neuroscience Letters.

[2]  M. Johnson,et al.  Additional signals from VPAC/PAC family receptors. , 2002, Biochemical Society transactions.

[3]  Yoh Iwasa,et al.  Saturation of Enzyme Kinetics in Circadian Clock Models , 2002, Journal of biological rhythms.

[4]  T. Bonner,et al.  Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. , 1994, Endocrinology.

[5]  M. Gillette,et al.  Signaling in the suprachiasmatic nucleus: selectively responsive and integrative , 2002, Cell and Tissue Research.

[6]  H. Marston,et al.  Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Cutler,et al.  Vasoactive intestinal polypeptide (VIP) phase‐shifts the rat suprachiasmatic nucleus clock in vitro , 2001, The European journal of neuroscience.

[8]  A. Harmar,et al.  Circadian changes in PACAP type 1 (PAC1) receptor mRNA in the rat suprachiasmatic and supraoptic nuclei , 1998, Brain Research.

[9]  J. Vanecek,et al.  Melatonin inhibits the increase of cyclic AMP in rat suprachiasmatic neurons induced by vasoactive intestinal peptide , 1998, Neuroscience Letters.

[10]  H. Kitano,et al.  Robust oscillations within the interlocked feedback model of Drosophila circadian rhythm. , 2001, Journal of theoretical biology.

[11]  P. Robberecht,et al.  Comparative efficacy of VIP and analogs on activation and internalization of the recombinant VPAC2 receptor expressed in CHO cells , 2004, Peptides.

[12]  J. Hannibal,et al.  Vasoactive intestinal polypeptide induces per1 and per2 gene expression in the rat suprachiasmatic nucleus late at night , 2002, The European journal of neuroscience.

[13]  Alec J Davidson,et al.  SCN: ringmaster of the circadian circus or conductor of the circadian orchestra? , 2003, Novartis Foundation symposium.

[14]  R. Jensen,et al.  The gastrin-releasing peptide receptor is differentially coupled to adenylate cyclase and phospholipase C in different tissues. , 1997, Biochimica et biophysica acta.

[15]  Imre Kalló,et al.  Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites , 2004, The Journal of comparative neurology.

[16]  E. Maywood,et al.  The VPAC2 Receptor Is Essential for Circadian Function in the Mouse Suprachiasmatic Nuclei , 2002, Cell.

[17]  M. Rosbash,et al.  Why the Rat-1 Fibroblast Should Replace the SCN as the In Vitro Model of Choice , 1998, Cell.

[18]  L. Fitzgerald,et al.  Measurement of responses from Gi-, Gs-, or Gq-coupled receptors by a multiple response element/cAMP response element-directed reporter assay. , 1999, Analytical biochemistry.

[19]  K. Shinohara,et al.  Temporal profiles of vasoactive intestinal polypeptide precursor mRNA and its receptor mRNA in the rat suprachiasmatic nucleus. , 1999, Brain research. Molecular brain research.

[20]  Paolo Sassone-Corsi,et al.  Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Korf,et al.  Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence , 1996, Cell and Tissue Research.

[22]  A. Couvineau,et al.  VPAC receptors for VIP and PACAP. , 2002, Receptors & channels.

[23]  M. A. Rea VIP-stimulated cyclic AMP accumulation in the suprachiasmatic hypothalamus , 1990, Brain Research Bulletin.

[24]  Upinder S Bhalla,et al.  Use of Kinetikit and GENESIS for modeling signaling pathways. , 2002, Methods in enzymology.

[25]  A. Goldbeter,et al.  Toward a detailed computational model for the mammalian circadian clock , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Lawrence F. Shampine,et al.  The MATLAB ODE Suite , 1997, SIAM J. Sci. Comput..

[27]  Erik D Herzog,et al.  Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons , 2005, Nature Neuroscience.

[28]  I. Rubinstein,et al.  Liposomal vasoactive intestinal peptide. , 2005, Methods in enzymology.

[29]  M. Johnson,et al.  Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor. , 2001, Endocrinology.

[30]  P. Mangeat,et al.  Parallel activation of cyclic AMP phosphodiesterase and cyclic AMP-dependent protein kinase in two human gut adenocarcinoma cells (HT 29 and HRT 18) in culture, by vasoactive intestinal peptide (VIP) and other effectors activating the cyclic AMP system , 1981, Regulatory Peptides.

[31]  A. Harmar,et al.  Transgenic approach reveals expression of the VPAC2 receptor in phenotypically defined neurons in the mouse suprachiasmatic nucleus and in its efferent target sites , 2004, The European journal of neuroscience.

[32]  A. Goldbeter,et al.  Modeling the mammalian circadian clock: sensitivity analysis and multiplicity of oscillatory mechanisms. , 2004, Journal of Theoretical Biology.

[33]  J. Lin,et al.  Synergistic activation of cAMP and calcium on cAMP-response-element-mediated gene expression in GH3 pituitary tumor cells. , 1996, Cellular signalling.

[34]  A. Saltelli,et al.  Sensitivity analysis for chemical models. , 2005, Chemical reviews.

[35]  Hanspeter Herzel,et al.  Entrainment in a Model of the Mammalian Circadian Oscillator , 2005, Journal of biological rhythms.

[36]  B. Rusak,et al.  Neuropeptides phase shift the mammalian circadian pacemaker , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  Daniel B. Forger,et al.  A detailed predictive model of the mammalian circadian clock , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Zoeller,et al.  Interaction of colocalized neuropeptides: functional significance in the circadian timing system , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.